Matsunaga K, Klein TW, Newton C, Friedman H, and Yamamoto Y
Legionella pneumophila and Interleukin-12 Production. In Vitro Infection Model. Legionella. 120-123. ASM press, 2002.
Oka A, Hirano T, Yamaji Y, Ito K, Oishi K, Edakuni N, Kawano R, Matsunaga K
Determinants of Incomplete Asthma Control in Patients with Allergic Rhinitis and Asthma. The Journal of Allergy and Clinical Immunology: In Practice. 5(1):160-164,DOI:10.1016/j.jaip.2016.08.002, 2017
Matsunaga K, Hirano T, Oka A, Ito K, Edakuni N
Persistently high exhaled nitric oxide and loss of lung function in controlled asthma. Allergol Int 65(3):266-71, DOI:10.1016/j.alit.2015.12.006, 2016
Hayata A, Minakata Y, Matsunaga K, Nakanishi M, Yamamoto N
Differences in physical activity according to mMRC grade in patients with COPD. International Journal of COPD 11(1):2203-2208, DOI:10.2147/COPD.S1096942016, 2016
Keiji Oishi, Keisuke Aoe, Yusuke Mimura, Yoriyuki Murata, Kenji Sakamoto, Wataru Koutoku, Tsuneo Matsumoto, Hiroshi Ueoka
Survival from an Acute Exacerbation of Idiopathic Pulmonary Fibrosis with or without Direct Hemoperfusion with a Polymyxin B-immobilized Fiber Column: A Retrospective Analysis. Internal Medicine, DOI: 10.2169/internalmedicine.55.6056, 2016
Matsunaga K, Hayata A, Akamatsu K, Hirano T, Tamada T, Kamei T, Tsuda T, Nakamura H, Takahashi T, Hozawa S, Mori Y, Sakamoto Y, Kimura K, Katsumata U, Miura M, Ichinose M
Stratifying the risk of COPD exacerbation using the modified Medical Reseach Council scale: A multicenter cross-sectional CAP study. Respir Investig, 53(2), 82-85, 2015.
Matsunaga K, Hirano T, Oka A, Tanaka A, Kanai K, Kikuchi T, Hayata A, Akamatsu H, Akamatsu K, Koh Y, Nakanishi M, Minakata Y, Yamamoto N
Progression of Irreversible Airflow Limitation in Asthma: Correlation with Severe Exacerbations. J Allergy Clin Immunol Pract, 3(5), 759-764, 2015.
Kanai K, Koarai A, Shishikura Y, Sugiura H, Ichikawa T, Kikuchi T, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M
Cigarette smoke augments MUC5AC production via the TLR3-EGFR pathway in airway epithelial cells. Respir Investig, 53(4), 137-148, 2015
Minakata Y, Morishita Y, Ichikawa T, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Ichinose M
Effects of pharmacologic treatment based on airflow limitation and breathlessness on daily physical activity in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis, 10, 1275-1282, 2015.
Matsunaga K, Ichikawa T, Oka A, Morishita Y, Kanai K, Hiramatsu M, Akamatsu H, Kawabata H, Kikuchi T, Akamatsu K, Hirano T, Koh Y, Nakanishi M, Minakata Y, Yamamoto N
Changes in forced expiratory volume in 1 second over time in patients with controlled asthma at baseline. Respir Med, 108(7), 976-982, 2014.
Ichikawa T, Sugiura H, Koarai A, Minakata Y, Kikuchi T, Morishita Y, Oka A, Kanai K, Kawabata H, Hiramatsu M, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Yamamoto N, Ichinose M
TLR3 Activation Augments Matrix Metalloproteinase Production through Reactive Nitrogen Species Generation in Human Lung Fibroblasts. J Immunol 192, 4977-4988, 2014.
Oka A, Matsunaga K, Kamei T, Sakamoto Y, Hirano T, Hayata A, Akamatsu K, Kikuchi T, Hiramatsu M, Ichikawa T, Nakanishi M, Minakata Y, Yamamoto N
Ongoing allergic rhinitis impairs asthma control by enhancing the lower airway inflammation. J Allergy Clin Immunol Pract, 2(2), 172-178, 2014.
Minakata Y, Sugino A, Kanda M, Ichikawa T, Akamatsu K, Koarai A, Hirano T, Nakanishi M, Sugiura H, Matsunaga K, Ichinose M
Reduced level of physical activity in Japanese patients with chronic obstructive pulmonary disease. Respir Investig, 52, 41-48, 2014.
Oda H, Kawayama T, Imaoka H, Sakazaki Y, Kaku Y, Okamoto M, Kitasato Y, Edakuni N, Takenaka S, Yoshida M, Iwanaga T, Kato S, O'Byrne PM, Hoshino T
Interleukin-18 expression, CD8(+) T cells, and eosinophils in lungs of nonsmokers with fatal asthma. Ann Allergy Asthma Immunol, 112(1), 23-28, 2014.
Minakata Y, Morishita Y, Hiramatsu M, Ichikawa T, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K and Ichinose M
Effect of Transdermal Tulobuterol Patch on the Physical Activity in Eight Male Subjects with Chronic Obstructive Pulmonary Disease. Clin Res Pulmonol, 1(2), 1010, 2013.
Inaba H, Hayakawa T, Miyamoto W, Takeshima K, Yamaoka H, Furukawa Y, Kawashima H, Ariyasu H, Wakasaki H, Furuta H, Nishi M, Nakao T, Sasaki H, Okada Y, Matsunaga K, Nakamura Y and Akamizu T
IgG4-related Ocular Adnexal Disease Mimicking Thyroid-associated Orbitopathy. Intern Med 52, 2545-2551, 2013.
Matsunaga K, Kawabata H, Hirano T, Sugiura H, Minakata Y, Ichinose M
Difference in time-course of improvement in asthma control measures between budesonide and budesonide/formoterol. Pulm Pharmacol Ther, 26(2), 189-194, 2013.
Hayata A, Matsunaga K, Hirano T, Akamatsu K, Ichikawa T, Minakata Y and Ichinose M
Stratifying a Risk for an Increased Variation of Airway Caliber among the Clinically Stable Asthma. Allergol Int, 62, 343-349, 2013.
Hirano T, Matsunaga K, Sugiura H, Minakata Y, Koarai A, Akamatsu K, Ichikawa T, Furukawa K, Ichinose M
Relationship between alveolar nitric oxide concentration in exhaled air and small airway function in COPD. J Breath Res, 7(4), 046002, 2013.
Matsunaga K, Hirano T, Akamatsu K and Minakata Y
Predictors for Identifying the Efficacy of Systemic Steroids on Sustained Exhaled Nitric Oxide Elevation in Severe Asthma. Allergol Int 62, 359-365, 2013.
Ichikawa T, Sugiura H, Koarai A, Kikuchi T, Hiramatsu M, Kawabata H, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M
25-Hydroxycholesterol promotes fibroblast-mediated tissue remodeling through NF-κβ dependent pathway. Exp Cell Res 319, 1176-1186, 2013.
Hirano T, Matsunaga K, Sugiura H, Minakata Y, Koarai A, Akamatsu K, Ichikawa T, Furukawa K, Ichinose M
Persistent elevation of exhaled nitric oxide and modification of corticosteroid therapy in asthma. Respir Investig 51, 84-91, 2013.
Matsunaga K, Kawabata H, Hirano T, Sugiura H, Minakata Y, Ichinose M
Difference in time-course of improvement in asthma control measures between budesonide and budesonide/formoterol. Pulm Pharmacol Ther 26(2), 189-194, 2013.
Matsunaga K, Akamatsu K, Miyatake A, Ichinose M
Natural history and risk factors of obstructive changes over a 10-year period in severe asthma. Respir Med 107(3), 355-360, 2013.
Sekiduka-Kumano T, Kawayama T, Ito K, Shoji Y, Matsunaga K, Okamoto M, Edakuni N, Imaoka H, Uchimura N, Hoshino T
Positive association between the plasma levels of 5-hydroxyindoleacetic acid and the severity of depression in patients with chronic obstructive pulmonary disease. BMC Psychiatry, 13, 159, 2013.
Sawada M, Kawayama T, Imaoka H, Sakazaki Y, Oda H, Takenaka S, Kaku Y, Azuma K, Tajiri M, Edakuni N, Okamoto M, Kato S, Hoshino T
IL-18 induces airway hyperresponsiveness and pulmonary inflammation via CD4+ T cell and IL-13, PLoS One, 8(1), e54623, 2013.
Koarai A, Yanagisawa S, Sugiura H, Ichikawa T, Kikuchi T, Furukawa K, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M
25-hydroxycholesterol enhances cytokine release and toll-like receptor 3 response in airway epithelial cells. Respir Res 13, 63, 2012.
Koarai A, Yanagisawa S, Sugiura H, Ichikawa T, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M
Cigarette smoke augments the expression and responses of toll-like receptor 3 in human macrophages. Respirology 17, 1018-1025, 2012.
Matsunaga K, Akamatsu K, Hirano T, Ichinose M
Response to treatment in individuals with late-onset asthma. J Am Geriatr Soc 60, 1587-1588, 2012.
Matsunaga K, Yanagisawa S, Hirano T, Ichikawa T, Koarai A, Akamatsu K, Sugiura H, Minakata Y, Matsunaga K, Kawayama T, Ichinose M
Associated demographics of persistent exhaled nitric oxide elevation in treated asthmatics. Clin Exp Allergy 42, 775-781, 2012.
Sugiura H, Koarai A, Ichikawa T, Minakata Y, Matsunaga K, Hirano T, Akamatsu K, Yanagisawa S, Furusawa M, Uno Y, Yamasaki M, Satomi Y, Ichinose M
Increased 25- hydroxycholesterol concentrations in the lungs of patients with chronic obstructive pulmonary disease. Respirology 17, 533-540, 2012.
Sugiura H, Kawabata H, Ichikawa T, Koarai A, Yanagisawa S, Kikuchi T, Minakata Y, Matsunaga K, Nakanishi M, Hirano T, Akamatsu K, Furukawa K, Ichinose M
Inhibitory effects of theophylline on the peroxynitrite-augmented release of matrix metalloproteinases by lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 302(8), L764-L774, 2012.
Kikuchi T, Sugiura H, Koarai A, Ichikawa T, Minakata Y, Matsunaga K, Nakanishi M, Hirano T, Akamatsu K, Yanagisawa S, Furukawa K, Kawabata H, Ichinose M
Increase of 27-hydroxycholesterol in the airways of patients with chronic obstructive pulmonary disease: possible role of 27-hydroxycholesterol in tissue fibrosis. Chest 142(2), 329-337, 2012.
Kanda M, Minakata Y, Matsunaga K, Sugiura H, Hirano T, Koarai A, Akamatsu K, Ichikawa T and Ichinose M
Validation of the Triaxial Accelerometer for the Evaluation of Physical Activity in Japanese Patients with COPD. Intern Med 51, 369-375, 2012.
Sugino A, Minakata Y, Kanda M, Akamatsu K, Koarai A, Hirano T, Sugiura H, Matsunaga K, Ichinose M
Validation of a Compact Motion Sensor for the Measurement of Physical Activity in Patients with Chronic Obstructive Pulmonary Disease. Respiration 83, 300-307, 2012.
Ito K, Kawayama T, Shoji Y, Fukushima N, Matsunaga K, Edakuni N, Uchimura N, Hoshino T
Depression, but not sleep disorder, is an independent factor affecting exacerbations and hospitalization in patients with chronic obstructive pulmonary disease, Respirology, 17(6), 940-949, 2012.
Akamatsu K, Matsunaga K, Sugiura H, Koarai A, Hirano T, Minakata Y and Ichinose M
Improvement of airflow limitation by fluticasone propionate/salmeterol in chronic obstructive pulmonary disease: what is the specific marker ? Front Pharmacol 2, 36, 2011.
Matsunaga K, Hirano T, Akamatsu K, Koarai A, Sugiura H, Minakata Y, Ichinose M
Exhaled nitric oxide cutoff values for asthma diagnosis according to rhinitis and smoking status in Japanese subjects. Allergol Int 60, 331-337, 2011.
Furukawa K, Sugiura H, Matsunaga K, Ichikawa T, Koarai A, Hirano T, Yanagisawa S, Minakata Y, Akamatsu K, Kanda M, Nishigai M and Ichinose M
Increase of nitrosative stress in patients with eosinophilic pneumonia. Respir Res 12, 81, 2011.
Matsunaga K, Hirano T, Kawayama T, Tsuburai T, Nagase H, Aizawa H, Akiyama K, Ohta K and Ichinose M
Reference ranges for exhaled nitric oxide fraction in healthy Japanese adult population. Allergol Int 59, 363-367, 2010.
Minakata Y, Ueda H, Akamatsu K, Kanda M, Yanagisawa S, Ichikawa T, Koarai A, Hirano T, Sugiura H, Matsunaga K, Ichinose M
High COPD prevalence in patients with liver diseases. Intern Med 49, 2687-2691, 2010.
Koarai A, Sugiura H, Yanagisawa S, Ichikawa T, Minakata Y, Matsunaga K, Hirano T, Akamatsu K, Ichinose M
Oxidative Stress Enhances Toll-like Receptor 3 Response to Double-stranded RNA in Airway Epithelial Cells. Am J Respir Cell Mol Biol 42, 651-660, 2010.
Matsunaga K, Ichikawa T, Yanagisawa S, Akamatsu K, Koarai A, Hirano T, Sugiura H, Minakata Y, Ichinose M
Clinical Application of Exhaled Breath Condensate Analysis in Asthma: Prediction of FEV・ Improvement by Steroid Therapy. Respiration 78, 393-398, 2009.
Yanagisawa S, Koarai A, Sugiura H, Ichikawa T, Kanda M, Tanaka R, Akamatsu K, Hirano T, Matsunaga K, Minakata Y, Ichinose M
Oxidative stress augments toll-like receptor 8 mediated neutrophilic responses in healthy subjects. Respir Res 10, 50, 2009.
Matsunaga K, Ichinose M
Issues and cautions of asthma management in elderly patients. International Review of Asthma 11, 34-41, 2009.
Sugiura H, Ichikawa T, Koarai A, Yanagisawa S, Minakata Y, Matsunaga K, Hirano T, Akamatsu K, Ichinose M
Activation of Toll-Like Receptor 3 Augments Myofibroblast Differentiation. Am J Respir Cell Mol Biol 40, 654-662, 2009.
Yanagisawa S, Sugiura H, Yokoyama T, Yamagata T, Ichikawa T, Akamatsu K, Koarai A, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M
The possible role of hematopoietic cell kinase in the pathophysiology of chronic obstructive pulmonary disease. Chest 135, 94-101, 2009.
Matsunaga K, Yanagisawa S, Ichikawa T, Akamatsu K, Koarai A, Hirano T, Sugiura H, Minakata Y, Ichinose M
Molecular Mechanism of the Additive Effects of Leukotriene Modifier in Asthmatic Patients Receiving Steroid Therapy. Allergol Int 58, 89-96, 2009.
Yamagata T, Yamagata Y, Nishimoto T, Hirano T, Nakanishi M, Minakata Y, Ichinose M, Dagenais A, Berthiaume Y
The regulation of amiloride-sensitive epithelial sodium channels by tumor necrosis factor-alpha in injured lungs and alveolar type II cells.Respir Physiol Neurobiol. 166(1):16-23,2009.
Okamoto M, Azuma K, Hoshino T, Imaoka H, Ikeda J, Kinoshita T, Takamori S, Ohshima K, Edakuni N, Kato S, Iwanaga T, Aizawa H
Correlation of decreased survival and IL-18 in bone metastasis, Intern Med, 48(10), 763-773, 2009.
Ichikawa T, Sugiura H, Koarai A, Yanagisawa S, Kanda M, Hayata A, Furukawa K, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M
Peroxynitrite augments fibroblast-mediated tissue remodeling via myofibroblast differentiation. Am J Physiol Lung Cell Mol Physiol 295, 800-808, 2008.
Matsunaga K, Kanda M, Hayata A, Yanagisawa S, Ichikawa T, Akamatsu K, Koarai A, Hirano T, Sugiura H, Minakata Y, Ichinose M
Peak Expiratory Flow Variability Adjusted by Forced Expiratory Volume in One Second is a Good Index for Airway Responsiveness in Asthmatics. Intern Med 47, 1107-1112, 2008.
Yamagata T, Hirano T, Sugiura H, Yanagisawa S, Ichikawa T, Ueshima K, Akamatsu K, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M
Comparison of bronchodilatory properties of transdermal and inhaled long-acting β2-agonists. Pulm Pharmacol Ther 21, 160-165, 2008.
Kawayama T, Minakata Y, Matsunaga K, Yamagata T, Tsuda T, Kinoshita M, Iwanaga T, Ichinose M, Aizawa H
Validation of symptom-based COPD questionnaires in Japanese subjects. Respirology 13, 420-426, 2008.
Minakata Y, Sugiura H, Yamagata T, Yanagisawa S, Ichikawa T, Koarai A, Akamatsu K, Hirano T, Matsunaga K, Ichinose M
Prevalence of COPD in Primary Care Clinics: Correlation with Non-Respiratory Diseases. Intern Med 47, 77-82, 2008.
Ichikawa T, Matsunaga K, Minakata Y, Yanagisawa S, Ueshima K, Akamatsu K, Hirano T, Nakanishi M, Sugiura H, Yamagata T, Ichinose M
Possible impact of salivary influence on cytokine analysis in exhaled breath condensate. Anal Chem Insights 2, 85-92, 2007.
Ueshima K, Minakata Y, Sugiura H, Yanagisawa S, Ichikawa T, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Yamagata T, Ichinose M
The Influence of Free 3-Nitrotyrosine and Saliva on the Quantitative Analysis of Protein-Bound 3-Nitrotyrosine in Sputum. Anal Chem Insights 2, 1-7, 2007.
Akamatsu K, Yamagata T, Takahashi T, Miura K, Maeda S, Yamagata Y, Ichikawa T, Yanagisawa S, Ueshima K, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M
Improvement of pulmonary function and dyspnea by tiotropium in COPD patients using a transdermal β2-agonist. Pulm Pharmacol Ther 20, 701-707, 2007.
Yamagata T, Sugiura H, Yokoyama T, Yanagisawa S, Ichikawa T, Ueshima K, Akamatsu K, Hirano T, Nakanishi M, Yamagata Y, Matsunaga K, Minakata Y, Ichinose M
Overexpression of CD-11b and CXCR1 on Circulating Neutrophils: Its Possible Role in COPD. Chest 132, 890-899, 2007.
Matsui D, Kitasato Y, Honda S, Ueno K, Tanaka A, Edakuni N, Mukaino T, Nishimura M, Kawayama T, Hoshino T, Fujimoto K, Koga T, Aizawa H
A case of bacterial pneumonia caused by Streptococcus dysgalactiae subsp. equisimilis, showing patchy consolidations resembling organizing pneumonia, Nihon Kokyuki Gakkai Zasshi, 45(1), 36-42, 2007.
Matsunaga K, Yamagata T, Minakata Y, Ichinose M
Importance of assistance by caregivers for inhaled corticosteroid therapy in elderly patients with asthma. J Am Geriatr Soc 54, 1626-1627, 2006.
Matsunaga K, Yanagisawa S, Ichikawa T, Ueshima K, Akamatsu K, Hirano T, Nakanishi M, Yamagata T, Minakata Y, Ichinose M
Airway cytokine expression measured by means protein array in exhaled breath condensate: Correlation with physiologic properties in asthmatic patients. J Allergy Clin Immunol 118, 84-90, 2006.
Hirano T, Yamagata T, Gohda M, Yamagata Y, Ichikawa T, Yanagisawa S, Ueshima K, Akamatsu K, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M
Inhibition of reactive nitrogen species production in COPD airways: comparison of inhaled corticosteroid and oral theophylline. Thorax 61, 761-766, 2006.
Matsunaga K, Yanagisawa S, Ichikawa T, Ueshima K, Akamatsu K, Hirano T, Nakanishi M, Yamagata T, Minakata Y, Ichinose M
Two Cases of Asthma in Handicapped Elderly Persons in Which Assisted Inhalation Therapy Was Effective. Allergol Int 55, 347-351, 2006.
Edakuni N, Ikuta K, Yano S, Nakataki E, Muguruma H, Uehara H, Tani M, Yokota J, Aizawa H, Sone S
Restored expression of the MYO18B gene suppresses orthotopic growth and the production of bloody pleural effusion by human malignant pleural mesothelioma cells in SCID mice, Oncol Res, 16(5), 235-243, 2006.
Ueno K, Kawayama T, Edakuni N, Koga T, Aizawa H
A case of thoracic empyema with gas formation associated with Streptococcus dysgalactiae subsp. Equisimilis, Kansenshogaku Zasshi, 80(5), 527-530, 2006.
Yamagata T, Okamoto Y, Yamagata Y, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M
Angioimmunoblastic lymphadenopathy with dysproteinaemia accompanied by pleural effusion. Respirology 10, 124-127, 2005.
Minakata Y, Nakanishi M, Hirano T, Matsunaga K, Yamagata T, Ichinose M
Microvascular hyperpermeability in chronic obstructive pulmonary disease airways. Thorax 60, 882, 2005.
Yano S, Muguruma H, Matsumori Y, Goto H, Nakataki E, Edakuni N, Tomimoto H, Kakiuchi S, Yamamoto A, Uehara H, Ryan A, Sone S
Antitumor vascular strategy for controlling experimental metastatic spread of human small-cell lung cancer cells with ZD6474 in natural killer cell-depleted severe combined immunodeficient mice, Clin Cancer Res, 11(24 Pt 1), 8789-98, 2005.
Yano S, Nakataki E, Ohtsuka S, Inayama M, Tomimoto H, Edakuni N, Kakiuchi S, Nishikubo N, Muguruma H, Sone S
Retreatment of lung adenocarcinoma patients with gefitinib who had experienced favorable results from their initial treatment with this selective epidermal growth factor receptor inhibitor: a report of three cases, 15(2), 107-111, 2005.
Yamamoto Y, Matsunaga K, Friedman H
Protective effects of green tea catechins on alveolar macrophages against bacterial infections. Biofactors 21(1-4), 119-121, 2004.
Matsunaga K, Nishimoto T, Hirano T, Nakanishi M, Yamagata T, Minakata Y, Kuroda M, Ikeda T, Nakanishi H and Ichinose M
Effect of a leukotriene receptor antagonist on the prevention of recurrent asthma attacks after an emergency room visit. Allergol Int 53(4), 341-347, 2004.
Yamagata T, Yamagata Y, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M
A case of primary lung cancer producing alpha-fetoprotein. Can Respir J 11, 504-506, 2004.
Hanibuchi M, Yano S, Edakuni N, Inayama M, Sone S
A case of early-stage lung cancer detected by autofluorescence bronchoscopy, J Med Invest, 51(3-4), 234-7, 2004.
Matsunaga K, Yamaguchi H, Klein TW, Friedman H, Yamamoto Y
Legionella pneumophila suppresses macrophage interleukin-12 production by activating the p42/44 mitogen-activated protein kinase cascade. Infect Immun 71(11), 6672-6675, 2003.
Yamagata T, Nakamura Y, Yamagata Y, Nakanishi M, Matsunaga K, Nakanishi H, Nishimoto T, Minakata Y, Mune M, Yukawa S
The pilot trial of the prevention of the increase in electrical taste thresholds by zinc containing fluid infusion during chemotherapy to treat primary lung cancer. J Exp Clin Cancer Res 22(4), 557-563, 2003.
Matsunaga K, Klein TW, Friedman H, and Yamamoto Y
Epigallocatechin Gallate, a Potential Immunomodulatory Agent of Tea Components, Diminishes Cigarette Smoke Condensate-Induced Suppression of Anti-Legionella pneumophila Activity and Cytokine Responses of Alveolar Macrophages. Clin Vaccine Immunol 9, 864-871, 2002.
Matsunaga K, Klein TW, Newton C, Friedman H, and Yamamoto Y
Beneficial Effects of Green Tea Catechins on Alveolar Macrophages Infected with Pneumoniae Causing Bacteria. Proceedings of 2001 international conference on tea culture and science, 151-153, 2002
Matsunaga K, Klein TW, Friedman H, and Yamamoto Y
In Vitro Therapeutic Effect of Epigallocatechin Gallate on Nicotine-Induced Impairment of Resistance to Legionella pneumophila Infection of Established MH-S Alveolar Macrophages. J Infect Dis 185, 229-236, 2002.
Matsunaga K, Klein TW, Friedman H, and Yamamoto Y
Involvement of Nicotinic Acetylcholine Receptors in Suppression of Antimicrobial Activity and Cytokine Responses of Alveolar Macrophages to Legionella pneumophila Infection by Nicotine. J Immunol 167, 6518-6524, 2001.
Matsunaga K, Klein TW, Friedman H, and Yamamoto Y
Legionella pneumophila Replication in Macrophages Inhibited by Selective Immunomodulatory Effects on Cytokine Formation by Epigallocatechin Gallate, A Major Form of Tea Catechins. Infect Immun 69, 3947-3953, 2001.
Matsunaga K, Klein TW, Friedman H, and Yamamoto Y
Alveolar Macrophage Cell Line MH-S Is Valuable as an In Vitro Model for Legionella pneumophila Infection. Am J Respir Cell Mol Biol 24, 326-331, 2001.
Matsunaga K, Klein TW, Newton C, Friedman H, and Yamamoto Y
Legionella pneumophila Suppresses Interleukin-12 Production by Macrophages. Infect Immun 69, 1929-1933, 2001.
Nakachi N, Matsunaga K, Friedman H, and Yamamoto Y
Differential Effects of Virulent versus Avirulent Legionella pneumophila on Chemokine Gene Expression in Murine Alveolar Macrophages Determined by cDNA Expression Array Technique. Infect Immun 68, 6069-6072, 2000.
平野綱彦
COPDへのSABAのアシストユース. PROGRESS IN MEDICINE 35: 255-260, 2015
学会報告
国際学会
【シンポジウム】
Matsunaga K
Clinical Application of Exhaled NO Measurements in COPD. The 25th Congress of Interasma Japan/North Asia, Yokohama, 2015.09.04
【一般演題】
Akamatsu H, Koh Y, Watanabe M, Kikuchi T, Nakanishi M, Matsunaga K, Yamamoto N
Establishment of multiplexed ultra-sensitive detection of epidermal growth factor receptor mutations using picodroplet digital PCR. American Association for Cancer Research Annual Meeting 2015, Philadelphia, Pennsylvania, USA, 2015.04.22
Matsunaga K, Oka A, Hayata A, Akamtsu K, Hirano T, Ichinose M
Statifying the risk of COPD exacerbation using the modified Medical Research Council scale: a multicenter cross-sectional CAP study. 2015 ATS International Conference, Denver, USA, 2015.05.19
Hirano T, Matsunaga K, Ogawa H, Minakata Y, Akamatsu K, Nakanishi M, Ichikawa T, Ichinose M
Effect of Inhaled Short-Acting Bate-2 Agonist (Procaterol) on Physical Activity of Patients with Chronic Obstructive Pulmonary disease. 2015 ATS International Conference, Denver, USA, 2015.05.18
Matusnaga K
PERSISTENTLY HIGH EXHALED NITRIC OXIDE AND LUNG FUNCTION DECLINE IN PATIENTS WITH CONTROLLED ASTHMA AT BASELINE. The 64th Meeting of Japanese Society of Allergology, 2015.05.28, Tokyo, Japan
